Non-HDL-C

More documents

Recommendations

Info

NCEP ATPIII, AHA, and ADA: Recommended Lipid Goals Parameter ATP III 1 AHA Women 2 (for adults ADA Position 3 with diabetes) LDL-C - Very high risk
Page 1 and 2: Current Targets and Treatment Gaps
Page 3 and 4: Fasting and Nonfasting TG: Equally
Page 5 and 6: Role of Low HDL-C in Residual Cardi
Page 7 and 8: Association Between LDL-C, Non-HDL-
Page 9 and 10: CHD risk predicted by HDL and LDL i
Page 11 and 12: New CV events in MI patients with n
Page 13 and 14: Percentage of patients reaching ADA
Page 15 and 16: IS THERE AN ASYMPTOTIC LIMIT FOR LD
Page 17 and 18: CAD risk can be reduced to a maximu
Page 19 and 20: Should both HDL-C and LDL- C be tar
Page 21: Should HDL Raising Be a Target for
Page 28 and 29: Recommendations for management of d
Page 32 and 33: NCEP ATP III Guidelines For all pat
Page 34 and 35: Priorities of Diabetic dyslipidemia
Page 36 and 37: Target Levels Risk Level Initiate t
Page 38: Target Levels Risk Level Initiate t
Page 45: Thank You 45

Non-HDL-C

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?